SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu Crypto is experiencing a surge in conversation fueled by its exceptionally active and dedicated community, which is relentlessly building a "permissionless brand" with numerous real-world products like Kendu Spice and Kendu Energy. This collective effort, marked by strong IRL initiatives and a long-term vision, sets KENDU apart, leading to a prevalent bullish sentiment across the crypto space.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending amid intense debate, as investors grapple with its persistent stock decline despite new strategic AI partnerships and potential tailwinds from discussions around credit card interest rate caps. While many criticize management and predict further drops given recent analyst downgrades, a significant portion of the community views PYPL as profoundly undervalued, actively accumulating shares and anticipating a strong rebound.

Monero

Monero (XMR) is trending strongly as its community champions it as the 'king of privacy' and the 'real Bitcoin' amid growing global discourse on digital anonymity. Despite discussions around regulatory scrutiny of privacy tokens, XMR demonstrates significant momentum, with users emphasizing its superior decentralization and robust technology over alternatives.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant buzz following robust preliminary financial updates, which highlighted record contract value and strong revenue expansion. The community is engaged in discussions surrounding its expanding partnerships with major pharmaceutical companies and key healthcare institutions, solidifying its role in leveraging AI for precision oncology and drug discovery. Investors maintain a bullish long-term outlook, emphasizing the company's foundational impact on healthcare technology.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is generating significant buzz following promising Phase 1 clinical data for CTX310, demonstrating deep and durable lipid reductions without serious adverse events. This breakthrough, published in The New England Journal of Medicine, validates the company's in vivo gene-editing platform and excites the community about its potential as a "one-and-done" treatment for severe lipid disorders. Investors anticipate substantial market recognition for this development, alongside ongoing pipeline progress in a field gaining new regulatory support.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is generating significant conversation driven by intense speculation around a potential acquisition, especially as the J.P. Morgan conference fuels rumors of a strategic buyer like Novartis eyeing its cardiovascular assets. The community is also closely monitoring ongoing legal proceedings concerning patent validity, with recent delays sparking varied interpretations, while strong preliminary financial results showing positive cash flow are contributing to a cautious optimism about the company's future value.

Rydex Investments - Invesco CurrencyShares British Pound Sterling Trust

Invesco CurrencyShares British Pound Sterling Trust

FXB is trending as recent weaker UK inflation and economic data have solidified market expectations for aggressive Bank of England rate cuts. The investment community is actively debating the implications of this monetary policy divergence, which is weighing significantly on the British Pound's value and driving conversation around sterling's immediate outlook against other major currencies.

Rydex Investments - Invesco CurrencyShares Euro Trust

Invesco CurrencyShares Euro Trust

The Invesco CurrencyShares Euro Trust is actively trending as the Euro shows resilience against the U.S. Dollar, largely driven by market speculation around potential shifts in Federal Reserve policy and concerns over its independence. The community is focused on how these dynamics, alongside mixed Eurozone data and contrasting central bank outlooks, are influencing EUR/USD exchange rates.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending due to a notable stock decline following a CFO transition and management's strategic emphasis on long-term user growth over near-term profits, despite reporting strong user metrics. This has created a polarized community discussion, with some investors fearing AI disruption and further valuation pressure, while others see an oversold opportunity for a long-term rebound.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is a key focus for investors, driven by a wave of new aircraft orders, including a major commitment from Alaska Airlines, and substantial defense contracts. The community is highly optimistic about Boeing's production ramp-up and strengthening financial position, signaling a robust outlook across its commercial and defense segments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.7% - Should You Sell?

ADMA Biologics (NASDAQ:ADMA) Shares Down 8.7% - Should You Sell...

ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference

ADMA Biologics (NASDAQ:ADMA) used its presentation at the J.P. Morgan Healthcare Conference to highlight a revenue pre-announcement for 2025, discuss manufacturing and supply chain developments, and...

Why Adma Biologics (ADMA) Outpaced the Stock Market Today

In the most recent trading session, Adma Biologics (ADMA) closed at $18.34, indicating a +1.72% shift from the previous trading day.

Allspring Global Investments Holdings LLC Sells 1,772,112 Shares of ADMA Biologics Inc $ADMA

Allspring Global Investments Holdings LLC decreased its position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 53.4% during the third quarter, according to its most recent filing...

ADMA Biologics Inc $ADMA Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 75.3% during the third quarter, according to the company in its most recent Form 13F filing with...

Harbor Capital Advisors Inc. Buys Shares of 59,801 ADMA Biologics Inc $ADMA

Harbor Capital Advisors Inc. purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...

Rice Hall James & Associates LLC Has $4.75 Million Stake in ADMA Biologics Inc $ADMA

Rice Hall James & Associates LLC cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 17.1% during the third quarter, according to its most recent 13F filing with the...

ADMA Biologics Inc $ADMA Shares Bought by Voya Investment Management LLC

Voya Investment Management LLC lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 3.9% during the third quarter, according to its most recent Form 13F filing with the...

Texas Permanent School Fund Corp Has $1.87 Million Holdings in ADMA Biologics Inc $ADMA

Texas Permanent School Fund Corp trimmed its stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 39.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and...

Perpetual Ltd Cuts Stake in ADMA Biologics Inc $ADMA

Perpetual Ltd cut its stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 26.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,119,291...

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Stocktwits

Stocktwits Polls

Traders are keenly discussing the impressive projected financials for 2026-2027, anticipating $635M-$775M in revenue and potential price targets up to $45.

Many investors view recent price drops and volatility as key opportunities to add more shares, praising rapid turnarounds from pullbacks.

Current Price	$17.93
Prev Close	$17.95
Open	$17.80
Dividend Yield	0.00%
50-Day Moving Average	$17.89
Beta	1.31
Avg. Volume	2.34M
PE Ratio	21.06

52-Week High	$25.67
52-Week Low	$13.50
Market Capitalization	$4.27B
EPS (Annual)	$0.8123
Price to Book	9.91
Revenue Per Employee	$622,560.58
Enterprise Value/EBITDA	N/A

ADMA
Adma Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADMA News

ADMAAdma Biologics Inc